Placenta Compositum

Product NDC

50114-7055

11-digit product format

501147055

Labeler code

50114

Product ID

50114-7055_cc3f0e8b-fc8c-4a62-b3e7-d70b061977e4

Type

HUMAN PRESCRIPTION DRUG

Nonproprietary name

HORSE CHESTNUT and LACTIC ACID, L- and CLAVICEPS PURPUREA SCLEROTIUM and CUPRIC SULFATE and MELILOTUS OFFICINALIS TOP and SUS SCROFA PLACENTA and SOLANUM NIGRUM WHOLE and STROPHANTHUS HISPIDUS SEED and SUS SCROFA EMBRYO and SODIUM PYRUVATE and SUS SCROFA VEIN and SUS SCROFA ARTERY and SUS SCROFA UMBILICAL CORD and TOBACCO LEAF and VIPERA BERUS VENOM and BARIUM CARBONATE and LEAD IODIDE

Dosage form

INJECTION

Route

INTRADERMAL; INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS

Labeler

Heel Inc

Marketing category

UNAPPROVED HOMEOPATHIC

Marketing start

2009-04-30

Marketing end

0000-00-00

Substance

HORSE CHESTNUT; LACTIC ACID, L-; CLAVICEPS PURPUREA SCLEROTIUM; CUPRIC SULFATE; MELILOTUS OFFICINALIS TOP; SUS SCROFA PLACENTA; SOLANUM NIGRUM WHOLE; STROPHANTHUS HISPIDUS SEED; SUS SCROFA EMBRYO; SODIUM PYRUVATE; SUS SCROFA VEIN; SUS SCROFA ARTERY; SUS SCROFA UMBILICAL CORD; TOBACCO LEAF; VIPERA BERUS VENOM; BARIUM CARBONATE; LEAD IODIDE

Active strength

4 [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL

Pharmacologic classes

Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Non-Standardized Plant Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Allergens [CS],Plant Proteins [CS]

NDC exclude flag

E

Listing certified through

2017-12-31

Current FDA listing

Historical FDA.report record